[PDF] Prevention of contrast induced acute kidney injury (CI-AKI) In adult patients

Renal Association
Renal Association
Publication date:
01 April 2013


The use of intravascular iodinated contrast agents has continued to increase over recent years. It is recognised that there are potential risks associated with the intravascular administration of iodinated contrast agents. It is, therefore, essential for the safe administration of iodinated contrast media, that those persons administering iodinated contrast media and those performing the imaging procedures have an understanding of the indications for use of iodinated contrast media as well as the potential side effects and their management. We would encourage practitioners, wherever practicable, to adopt the current trend towards reduced doses of intravenous iodinated contrast media due to the benefit of modern dual-head pumps and fast CT scanners. At the time of publishing these guidelines, investigations into the potential of low-kVp, low iodinated contrast dose CT technique, were in progress. These guidelines address the issues associated with administering iodinated contrast agents to adult patients only. For children and neonates a paediatric radiologist should be consulted.